PAM
NVO

Panagora Asset Management’s Novo Nordisk NVO Stock Holding History

Panagora Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,130
Closed -$217K – 2425
2016
Q4 		$217K Hold
12,130
– – ﹤0.01% 1730
2016
Q3 		$252K Buy
+12,130
New +$301K ﹤0.01% 1684
2014
Q3 		– Sell
-1,584
Closed -$37K – 2331
2014
Q2 		$37K Buy
+1,584
New +$35K ﹤0.01% 2153

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Panagora Asset Management's NVO Position: Q1 2017 in Review

Panagora Asset Management sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 12,130 shares — an estimated $217K sold.

Panagora Asset Management first reported a position in NVO in Q2 2014 and held it in 3 quarters. The position peaked at $252K in Q3 2016. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

  • Panagora Asset Management reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
  • Panagora Asset Management sold 12,130 Novo Nordisk shares in Q1 2017, an estimated $217K.
  • Panagora Asset Management first reported a position in Novo Nordisk in Q2 2014 and held it in 3 quarters.
  • Panagora Asset Management's Novo Nordisk position peaked at $252K in Q3 2016.
  • 463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Panagora Asset Management's 13F filing for Q1 2017, filed 15 May 2017.